BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9616881)

  • 1. [Radiologic diagnosis of bone metastases].
    Hansmann HJ; Wunsch C; Schneider B; Brado M; Flesch M; Richter GM; Kauffmann GW
    Orthopade; 1998 Apr; 27(4):224-30. PubMed ID: 9616881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metastatic bone disease. Strategies for imaging].
    Scutellari PN; Antinolfi G; Galeotti R; Giganti M
    Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer.
    Jones AL; Williams MP; Powles TJ; Oliff JF; Hardy JR; Cherryman G; Husband J
    Br J Cancer; 1990 Aug; 62(2):296-8. PubMed ID: 2386746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
    Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
    Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological diagnosis of skeletal metastases.
    Söderlund V
    Eur Radiol; 1996; 6(5):587-95. PubMed ID: 8934120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases.
    Traill ZC; Talbot D; Golding S; Gleeson FV
    Clin Radiol; 1999 Jul; 54(7):448-51. PubMed ID: 10437696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases.
    Brown B; Laorr A; Greenspan A; Stadalnik R
    Clin Nucl Med; 1994 Mar; 19(3):194-6. PubMed ID: 8033466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiologic detection of metastatic bone tumors].
    Sugimoto E; Tamagawa M; Okawara K; Osawa T
    Gan No Rinsho; 1988 Aug; 34(10):1491-7. PubMed ID: 3172506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Scientigraphic hot lesions secondary to osseous metastases in a patient with multiple myeloma].
    Ruiz Hernández G; Vázquez Forner C; Fliquete Peris MV
    Rev Esp Med Nucl; 2002; 21(5):362-5. PubMed ID: 12236912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic imaging of bone metastases].
    Scutellari PN; Addonisio G; Righi R; Giganti M
    Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
    Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
    Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiologic diagnosis of bone metastases].
    Rieden K; Adolph J; Mende U; Georgi P
    Rontgenblatter; 1989 Feb; 42(2):95-103. PubMed ID: 2648554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton.
    Ghanem N; Altehoefer C; Högerle S; Schäfer O; Winterer J; Moser E; Langer M
    Eur J Radiol; 2002 Sep; 43(3):256-61. PubMed ID: 12204408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of 99mTc-HMPAO-labeled leukocyte scintigraphy in the diagnosis of skeletal metastases of cancers.
    Kinoshita M; Imai Y; Fujiwara K; Miyamae T
    Ann Nucl Med; 2000 Apr; 14(2):103-9. PubMed ID: 10830527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer.
    Altehoefer C; Ghanem N; Högerle S; Moser E; Langer M
    Eur J Radiol; 2001 Oct; 40(1):16-23. PubMed ID: 11673003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors].
    Ghanem N; Kelly T; Altehoefer C; Winterer J; Schäfer O; Bley TA; Moser E; Langer M
    Radiologe; 2004 Sep; 44(9):864-73. PubMed ID: 15351930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic imaging of bone metastases.
    Heindel W; Gübitz R; Vieth V; Weckesser M; Schober O; Schäfers M
    Dtsch Arztebl Int; 2014 Oct; 111(44):741-7. PubMed ID: 25412631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.